НовостиBenzingaCitigroup Maintains Buy on Faeth Therapeutics, Raises Price Target to $60 Citigroup Maintains Buy on Faeth Therapeutics, Raises Price Target to $60 Benzinga 2026.11.10 19:17 (GMT+0) Открыть на Benzinga Другие новости